ReviewBreast cancer (Dove Medical Press)2022

Evaluating the Fragility of Long-Term Outcomes for Neoadjuvant versus Adjuvant Chemotherapy Prescription in Early Breast Cancer: Pooled Data from 10 Randomised Clinical Trials.

Matthew G Davey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.